Guanhao Biotech Co (SZSE:300238) Short-Term Debt & Capital Lease Obligation : ¥30.9 Mil (As of Mar. 2024)

View and export this data going back to 2011. Start your Free Trial

What is Guanhao Biotech Co Short-Term Debt & Capital Lease Obligation?

Short-Term Debt & Capital Lease Obligation is the portion of a company's debt and capital lease obligation that need to be paid within the next 12 months. It equals Short-Term Debt plus Short-Term Capital Lease Obligation. This gives investors an idea of how much money the company needs to pay down for the principle of its debt. Guanhao Biotech Co's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2024 was ¥30.9 Mil.

Long-Term Debt & Capital Lease Obligation is the debt and capital lease obligation due more than 12 months in the future. Guanhao Biotech Co's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2024 was ¥46.1 Mil.

Guanhao Biotech Co Short-Term Debt & Capital Lease Obligation Historical Data

The historical data trend for Guanhao Biotech Co's Short-Term Debt & Capital Lease Obligation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Guanhao Biotech Co Short-Term Debt & Capital Lease Obligation Chart

Guanhao Biotech Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Short-Term Debt & Capital Lease Obligation

Get a 7-Day Free Trial

163.41

163.75

115.76

56.54

30.59

Guanhao Biotech Co Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Short-Term Debt & Capital Lease Obligation	Get a 7-Day Free Trial															55.76	45.50	30.19	30.59	30.95

Guanhao Biotech Co Short-Term Debt & Capital Lease Obligation Calculation

This is the portion of a company's debt and capital lease obligation that need to be paid within the next 12 months. It equals Short-Term Debt plus Short-Term Capital Lease Obligation. This gives investors an idea of how much money the company needs to pay down for the principle of its debt.

In the notes to balance sheet in annual (10-K) or quarterly (10-Q) reports, companies usually break down the details of the debt, their due dates, the interest rates etc.

Be Aware

Stay away from companies that roll over the debt e.g. Bear Stearns

When investing in financial institutions, Buffett shies from those who are bigger borrowers of short term than long term debt.

His favorite Wells Fargo has 57 cents short term debt for every dollar of long term

Aggressive banks (like Bank of America) has $2.09 short term for every dollar long term

Guanhao Biotech Co Short-Term Debt & Capital Lease Obligation Related Terms

Thank you for viewing the detailed overview of Guanhao Biotech Co's Short-Term Debt & Capital Lease Obligation provided by GuruFocus.com. Please click on the following links to see related term pages.

Guanhao Biotech Co (SZSE:300238) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Guanhao Biotech Co Ltd (SZSE:300238) » Definitions » Short-Term Debt & Capital Lease Obligation

Comparable Companies

Traded in Other Exchanges

N/A

Address

No.12 Yuyan Road, Luogang District, Guangdong, Guangzhou, CHN, 510530

Website

http://www.grandhopebio.com

Guanhao Biotech Co Ltd is a China-based biotech company. It develops, manufactures and markets life and health-related products, with focus on regenerative medicines for the treatment of damaged tissue and organs. Its products include NormalGEN dura repair patch, GrandNeuro (Type B) dura repair patch, ThromalGEN (Type P) surgical patch, Guanhao-ACI, among others.

Executives

Liu De Wang	Directors, executives
Zhao Jun Hui	Directors, executives
Yang Guo Sheng	Supervisors
Zhu Wei Ping	Director
Hu Jun	Securities Affairs Representative
Jia Bao Rong	Executives
Jia Jun Chao	Executives
Di Pu	Director
Zhuo Fu Min	Director
Guo Xiao Ming	Executives
Zhang Hong Tao	Executives
Zhao Wen Jie	Executives
Guan Xin	Director

Guanhao Biotech Co (SZSE:300238) Headlines

No Headlines